| Authors: |
Dergai O; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Wuu J; Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, FL, USA., Koziczak-Holbro M; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Malaspina A; UCL Queen Square Motor Neuron Disease Center, UCL Queen Square Institute of Neurology, University College London, Queen Square, London, UK., Granit V; Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, FL, USA., Hernandez JP; Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, FL, USA., Cooley A; Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, FL, USA., Sachdev R; Biomarker Development, Novartis Biomedical Research, Basel, Switzerland., Yu L; Biomarker Development, Novartis Biomedical Research, Cambridge, MA, USA., Bidinosti M; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Flotte L; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Nash M; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Jennings LL; Disease Area X, Novartis Biomedical Research, Cambridge, MA, USA., Berry JD; Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA., Bruijn LI; Biomarker Development, Novartis Pharmaceuticals, London, UK., Brachat S; Diseases of Aging and Regenerative Medicine, Novartis Biomedical Research, Basel, Switzerland., Benatar M; Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, FL, USA. |
